CMPX SG&A Expense Growth
Compass Therapeutics · SG&A Expense Growth
CMPX SG&A Expense Growth
Latest reported11.48%period ending
CMPX FY SG&A Growth (YoY) (0.00% → 11.48%)
Latest values, visible window
High-resolution chart · PNG
CMPX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 11.4782% | |
| 23.6053% | |
| 5.018% | |
| 6.6899% | |
| -15.3471% | |
| 11.2471% | |
| 3.4412% | |
| 0% |